Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.

Benjamin LA, Paterson RW, Moll R, Pericleous C, Brown R, Mehta PR, Athauda D, Ziff OJ, Heaney J, Checkley AM, Houlihan CF, Chou M, Heslegrave AJ, Chandratheva A, Michael BD, Blennow K, Vivekanandam V, Foulkes A, Mummery CJ, Lunn MP, Keddie S, Spyer MJ, Mckinnon T, Hart M, Carletti F, Jäger HR, Manji H, Zandi MS, Werring DJ, Nastouli E, Simister R, Solomon T, Zetterberg H, Schott JM, Cohen H, Efthymiou M, UCLH Queen Square COVID-19 Biomarker Study group.

Open source

DOI
10.1016/j.eclinm.2021.101070
Published
2021-08-12
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2021.101070,
  title = {Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.},
  author = {Benjamin LA and  Paterson RW and  Moll R and  Pericleous C and  Brown R and  Mehta PR and  Athauda D and  Ziff OJ and  Heaney J and  Checkley AM and  Houlihan CF and  Chou M and  Heslegrave AJ and  Chandratheva A and  Michael BD and  Blennow K and  Vivekanandam V and  Foulkes A and  Mummery CJ and  Lunn MP and  Keddie S and  Spyer MJ and  Mckinnon T and  Hart M and  Carletti F and  Jäger HR and  Manji H and  Zandi MS and  Werring DJ and  Nastouli E and  Simister R and  Solomon T and  Zetterberg H and  Schott JM and  Cohen H and  Efthymiou M and  UCLH Queen Square COVID-19 Biomarker Study group.},
  year = {2021},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2021.101070},
  url = {https://doi.org/10.1016/j.eclinm.2021.101070}
}

RIS

TY  - JOUR
TI  - Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
AU  - Benjamin LA
AU  -  Paterson RW
AU  -  Moll R
AU  -  Pericleous C
AU  -  Brown R
AU  -  Mehta PR
AU  -  Athauda D
AU  -  Ziff OJ
AU  -  Heaney J
AU  -  Checkley AM
AU  -  Houlihan CF
AU  -  Chou M
AU  -  Heslegrave AJ
AU  -  Chandratheva A
AU  -  Michael BD
AU  -  Blennow K
AU  -  Vivekanandam V
AU  -  Foulkes A
AU  -  Mummery CJ
AU  -  Lunn MP
AU  -  Keddie S
AU  -  Spyer MJ
AU  -  Mckinnon T
AU  -  Hart M
AU  -  Carletti F
AU  -  Jäger HR
AU  -  Manji H
AU  -  Zandi MS
AU  -  Werring DJ
AU  -  Nastouli E
AU  -  Simister R
AU  -  Solomon T
AU  -  Zetterberg H
AU  -  Schott JM
AU  -  Cohen H
AU  -  Efthymiou M
AU  -  UCLH Queen Square COVID-19 Biomarker Study group.
PY  - 2021
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2021.101070
UR  - https://doi.org/10.1016/j.eclinm.2021.101070
ER  - 

APA

LA, B., RW, P., R, M., C, P., R, B., PR, M., D, A., OJ, Z., J, H., AM, C., CF, H., M, C., AJ, H., A, C., BD, M., K, B., V, V., A, F., CJ, M., MP, L., S, K., MJ, S., T, M., M, H., F, C., HR, J., H, M., MS, Z., DJ, W., E, N., R, S., T, S., H, Z., JM, S., H, C., M, E., & group., U. Q. S. C. B. S. (2021). Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.101070

Source records